Alexion CEO Hantson Tasked With Kicking Growth Momentum Into Gear
Executive Summary
The rare disease specialist’s new CEO is former Baxalta CEO Ludwig Hantson, who takes over the helm immediately after a leadership shakeup coinciding with an audit investigation.